Table 2 Clinical/histopathological diagnosis, presence of anti-rabphilin-3A (RPH3A) antibodies, and the interval between onset and blood sampling in 15 patients with central diabetes insipidus.
Case | Diagnosis | RPH3A antibodies | Interval between the onset and blood sampling | Follow-up periods after clinical diagnosis |
|---|---|---|---|---|
5 | LINH |  +  | 1 month | 5 years 5 months |
7 | LINH |  +  | 1 month | 4 years 6 months |
9 | LINH |  +  | 2 months | 3 years 9 months |
11 | LINH |  +  | 2 months | 2 year 4 months |
14 | LINH | − | 3 months | 1 year 5 months |
3 | LPH |  +  | 2 months | 6 years 10 months |
6 | LPH |  +  | 2 months | − |
10 | LPH | − | 6 months | − |
12 | LPH |  +  | 1 month | − |
1 | Sarcoidosis |  +  | 1 month | 7 years 9 months |
4 | Sarcoidosis | − | 6 months | 6 years 2 months |
2 | Rathke cleft cyst | − | 2 months | − |
15 | Rathke cleft cyst | − | 1 month | − |
8 | Craniopharyngioma | − | 4 months | − |
13 | Germinoma |  +  | 7 months | − |
